| Product Code: ETC11262213 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Adeno Associated Virus Gene Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Adeno Associated Virus Gene Therapy Market - Industry Life Cycle |
3.4 China Adeno Associated Virus Gene Therapy Market - Porter's Five Forces |
3.5 China Adeno Associated Virus Gene Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 China Adeno Associated Virus Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Adeno Associated Virus Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of genetic disorders in China |
4.2.2 Increasing RD investments in gene therapy by pharmaceutical companies |
4.2.3 Favorable government regulations and policies supporting gene therapy research and development in China |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy treatment |
4.3.2 Challenges in manufacturing and scaling up gene therapy production |
4.3.3 Limited awareness and acceptance of gene therapy among patients and healthcare providers in China |
5 China Adeno Associated Virus Gene Therapy Market Trends |
6 China Adeno Associated Virus Gene Therapy Market, By Types |
6.1 China Adeno Associated Virus Gene Therapy Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.1.4 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Cancer, 2021 - 2031F |
6.1.5 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.1.6 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Adeno Associated Virus Gene Therapy Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.2.3 China Adeno Associated Virus Gene Therapy Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 China Adeno Associated Virus Gene Therapy Market Import-Export Trade Statistics |
7.1 China Adeno Associated Virus Gene Therapy Market Export to Major Countries |
7.2 China Adeno Associated Virus Gene Therapy Market Imports from Major Countries |
8 China Adeno Associated Virus Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials for adeno-associated virus gene therapy in China |
8.2 Adoption rate of adeno-associated virus gene therapy in major healthcare institutions |
8.3 Number of partnerships and collaborations between Chinese and international gene therapy companies |
8.4 Investment trends in gene therapy research and development in China |
8.5 Patient outcomes and success rates of adeno-associated virus gene therapy treatments in China |
9 China Adeno Associated Virus Gene Therapy Market - Opportunity Assessment |
9.1 China Adeno Associated Virus Gene Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Adeno Associated Virus Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Adeno Associated Virus Gene Therapy Market - Competitive Landscape |
10.1 China Adeno Associated Virus Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Adeno Associated Virus Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here